Loading...
Docoh

Morphosys (MOR)

MorphoSys AG engages in the development of antibodies for therapeutic, diagnostics, and research applications. It operates through the Proprietary Development and Partnered Discovery segments. The Proprietary Development segment combines proprietary research and development of therapeutic compounds. The Partnered Discovery segment offers technologies to make human antibody-based therapeutics on behalf of partners in the pharmaceutical industry. The company was founded by Andreas Pluckthun and Simon E. Moroney in July 1992 and is headquartered in Planegg, Germany.

MOR stock data

Calendar

16 Mar 22
28 Sep 22
31 Dec 22
Quarter (USD) Dec 21 Dec 20 Dec 19 Dec 18
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD) Dec 21 Dec 20 Dec 19 Dec 18
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
13F holders Current Prev Q Change
Total holders 0 0
Opened positions 0 0
Closed positions 0 1 EXIT
Increased positions 0 0
Reduced positions 0 0
13F shares Current Prev Q Change
Total value 0 0
Total shares 0 0
Total puts 0 0
Total calls 0 0
Total put/call ratio
Largest owners Shares Value Change
Largest transactions Shares Bought/sold Change

Financial report summary

?

Content analysis

?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. sophomore Avg
New words: absorbed, AC, ACE, Aduhelm, advanceCOR, affirming, alert, alopecia, ambition, AML, amortised, amplification, ancestry, androgen, anymore, aquisition, argued, ASN, asthenic, authoritative, basket, BET, bioresearch, birth, border, Bridgewater, built, Cadillac, calcineurin, cashflow, Castle, castration, CDE, Chase, chromatin, clawback, climate, color, commandeered, COMP, congestive, Constellation, constitutionality, COO, corroborated, counterfeit, covid, creatinine, cut, cutoff, Dear, debtor, digital, DIGITALIZATION, discomfort, discriminated, Dover, downregulate, downturn, drawdown, DROIA, dysgeusia, dysregulated, ebb, edema, elicit, endometrial, enzymatic, epidemic, epigenetic, erythroid, ESPRIT, excessive, excise, extranodal, fedratinib, felzartamb, fever, fifteen, filter, FLAC, footprint, FVOCI, FVTPL, fx, gantenumerab, Goldman, gouging, Heaf, hematoma, hematopoietic, hemoglobin, hemorrhage, histology, Horvart, host, hot, hour, hub, hurdle, hyperkalemia, hyperuricemia, ICAV, ID, IgAN, IGNAZ, immature, implicated, inequity, InnoCare, INSEAD, instated, instructed, intentionally, interdisciplinary, interoperable, interstitial, IRR, Jakafi, Joe, JPMorgan, KDIGO, leader, leaking, LEAN, lection, linearly, LLS, losscarryback, MANIFEST, masculine, McGrogan, megakaryocyte, mesangial, mesangium, methyl, MF, military, Mill, MINDway, mininum, Minjuvi, momelotinib, moratorium, multiorgan, musculoskeletal, MYC, mycophenolat, myelosuppression, Nephrology, nodal, Omicron, oncogenic, Orange, overcame, overexpression, parameter, pecuniary, pelabresib, Pelapresib, permission, pickup, PIP, Planing, platelet, postponed, Powder, Pozdizk, prostate, provisionally, PTE, pyrexia, race, readability, recognizable, reconsider, remote, reordered, repressed, reprogramming, resurgence, Ronco, ruxolitinib, Rybrevant, scarcity, scarring, SDAX, sex, Sixteen, SPC, spleen, splenic, splenomegaly, SPPI, STOXX, stratified, subdural, suboptimal, sunset, TCA, TD, thrombocythemia, thromboembolic, thromobocytopenia, tired, toll, topmind, tracing, transfusion, transitory, translocation, traumatic, trimester, tripped, Troyanov, Trujillo, TSS, turnaround, Ukraine, Ukrainian, Ultragenyx, unanimously, underestimate, unfinished, unfit, unfounded, unlock, unnecessary, unrestricted, unspecified, UPCR, upside, upstream, upward, urothelial, variance, wage, Wagner, warehousing, water, wholesale, Wilmington, writer
Removed: absent, Academy, adalimumab, admissible, advancement, agenda, allele, Allianz, analyzing, Anderson, apparent, arose, ascending, Austria, bargaining, BayernLB, begun, belong, blackout, BNP, borrower, bowel, breakdown, bridging, Bruton, BTD, BTK, BTKi, Bundesfinanzhof, Bundesverfassungsgericht, cancelable, capped, causal, checkpoint, cleared, clostridium, collectible, Commerzbank, compensated, concealing, confirmation, confusional, constitution, continually, contracted, Cosentyx, crohn, crossover, deal, decreasing, dehydration, dehydrogenase, deliberately, demonstrating, dermatology, difficile, diploma, disappeared, discrete, dossier, dropout, EADV, EBITDA, ECLIPSE, eleven, EME, erythrodermic, exact, exchanged, exercisability, exhibited, exploring, extraterritorially, facial, falsifying, fashion, flushing, Freigrenze, fumaric, GALAXI, genital, Genmab, Gesellschaft, golimumab, Groningen, guselkumab, guttate, hired, hospitalia, HS, Humira, hypercalcaemia, hyponatraemia, idelalisib, IGUANA, incomplete, indolent, iNHL, injector, intelligence, intensified, intravenously, inverse, invesco, itchy, IWCLL, jirovecii, Journal, Kabi, Kliniken, labor, lactate, LanthioPep, lanthipeptide, Las, LBBW, learn, LEN, leukopenia, live, Load, localized, London, Lynch, mantle, Marburg, MD, MDAX, meant, mediastinal, Memorandum, Merrill, minimal, misread, moderately, monkey, monospecific, MRD, multiplying, myelodysplastic, NAVIGATE, negativity, netted, NOVA, NOXXON, nutrition, NV, occupational, Organ, outperform, overhaul, PASI, percent, periphery, preferable, probing, proportional, ProServe, PROTOSTAR, PsA, PSSD, pustular, ranging, recombinant, Reneo, repealing, researched, researching, Richter, risen, rose, rounding, scaly, schematic, scientifically, secukinumab, SEER, shortly, SLL, Sparkasse, stabilized, stand, stelara, subcutaneously, subdivided, subsidy, Summit, suppurativa, switched, Tabular, Takeda, thoracic, tracer, transmit, tyrosine, UC, ulcerative, unaffected, unallocated, unbilled, uneconomical, UniCredit, unrecognized, ustekinumab, utomilumab, VAT, VEGA, Venereology, venetoclax, VOYAGE, warm, watch, Wittgensteiner, worth, wrong, yielding, Zinsschranke
Proxies
No filings